Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.
Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.
How can payers cope with new, ultra-expensive therapies?
The new CGRP therapies provide a novel, migraine-specific mechanism with effective results. Read more.
No longer a technology for science fiction, artificial intelligence and machine learning offer the multifaceted approach that healthcare is waiting for.
There are many ways to measure success and value—but the future of value-based care will rely on patient-reported outcomes.
To get a pulse on the U.S.
Douglas Long, vice president of industry relations at Durham, NC-based IQVIA, a newly named company after the merger of IMS Health and Quintiles, discussed pharmaceutical marketplace trends during the headline session at the Academy of Ma
A diabetes patient’s ambivalence about changing their diet or taking their insulin can stand between successful management of their disease and a further escalation that could lead to blindness, limb removal, or even death.
Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.